Cho SY - Search Results

1

A novel cereblon modulator for targeted protein degradation.

Kim SA, Go A, Jo SH, Park SJ, Jeon YU, Kim JE, Lee HK, Park CH, Lee CO, Park SG, Kim P, Park BC, Cho SY, Kim S, Ha JD, Kim JH, Hwang JY. Kim SA, et al. Among authors: cho sy. Eur J Med Chem. 2019 Mar 15;166:65-74. doi: 10.1016/j.ejmech.2019.01.023. Epub 2019 Jan 17. Eur J Med Chem. 2019. PMID: 30684871

2

Synthesis and PTP1B inhibition of 1,2-naphthoquinone derivatives as potent anti-diabetic agents.

Ahn JH, Cho SY, Ha JD, Chu SY, Jung SH, Jung YS, Baek JY, Choi IK, Shin EY, Kang SK, Kim SS, Cheon HG, Yang SD, Choi JK. Ahn JH, et al. Among authors: cho sy. Bioorg Med Chem Lett. 2002 Aug 5;12(15):1941-6. doi: 10.1016/s0960-894x(02)00331-1. Bioorg Med Chem Lett. 2002. PMID: 12113814

3

PTP-1B inhibitors: cyclopenta[d][1,2]-oxazine derivatives.

Cho SY, Baek JY, Han SS, Kang SK, Ha JD, Ahn JH, Lee JD, Kim KR, Cheon HG, Rhee SD, Yang SD, Yon GH, Pak CS, Choi JK. Cho SY, et al. Bioorg Med Chem Lett. 2006 Feb;16(3):499-502. doi: 10.1016/j.bmcl.2005.10.062. Epub 2005 Nov 8. Bioorg Med Chem Lett. 2006. PMID: 16289879

4

Synthesis and biological evaluation of rhodanine derivatives as PRL-3 inhibitors.

Ahn JH, Kim SJ, Park WS, Cho SY, Ha JD, Kim SS, Kang SK, Jeong DG, Jung SK, Lee SH, Kim HM, Park SK, Lee KH, Lee CW, Ryu SE, Choi JK. Ahn JH, et al. Among authors: cho sy. Bioorg Med Chem Lett. 2006 Jun 1;16(11):2996-9. doi: 10.1016/j.bmcl.2006.02.060. Epub 2006 Mar 10. Bioorg Med Chem Lett. 2006. PMID: 16530413

5

Discovery of aminopyridines substituted with benzoxazole as orally active c-Met kinase inhibitors.

Cho SY, Han SY, Ha JD, Ryu JW, Lee CO, Jung H, Kang NS, Kim HR, Koh JS, Lee J. Cho SY, et al. Bioorg Med Chem Lett. 2010 Jul 15;20(14):4223-7. doi: 10.1016/j.bmcl.2010.05.031. Epub 2010 May 15. Bioorg Med Chem Lett. 2010. PMID: 20570511

6

Evaluation of a multi-kinase inhibitor KRC-108 as an anti-tumor agent in vitro and in vivo.

Han SY, Lee CO, Ahn SH, Lee MO, Kang SY, Cha HJ, Cho SY, Ha JD, Ryu JW, Jung H, Kim HR, Koh JS, Lee J. Han SY, et al. Among authors: cho sy. Invest New Drugs. 2012 Apr;30(2):518-23. doi: 10.1007/s10637-010-9584-2. Epub 2010 Nov 16. Invest New Drugs. 2012. PMID: 21080208

7

Design and synthesis of triazolopyridazines substituted with methylisoquinolinone as selective c-Met kinase inhibitors.

Ryu JW, Han SY, Yun JI, Choi SU, Jung H, Ha JD, Cho SY, Lee CO, Kang NS, Koh JS, Kim HR, Lee J. Ryu JW, et al. Among authors: cho sy. Bioorg Med Chem Lett. 2011 Dec 1;21(23):7185-8. doi: 10.1016/j.bmcl.2011.09.066. Epub 2011 Sep 22. Bioorg Med Chem Lett. 2011. PMID: 22001029

8

Design and synthesis of 3-(4,5,6,7-tetrahydro-3H-imidazo[4,5-c]pyridin-2-yl)-1H-quinolin-2-ones as VEGFR-2 kinase inhibitors.

Han SY, Choi JW, Yang J, Chae CH, Lee J, Jung H, Lee K, Ha JD, Kim HR, Cho SY. Han SY, et al. Among authors: cho sy. Bioorg Med Chem Lett. 2012 Apr 15;22(8):2837-42. doi: 10.1016/j.bmcl.2012.02.073. Epub 2012 Mar 7. Bioorg Med Chem Lett. 2012. PMID: 22450128

9

Synthesis and structure-activity relationship of aminopyridines with substituted benzoxazoles as c-Met kinase inhibitors.

Lee J, Han SY, Jung H, Yang J, Choi JW, Chae CH, Park CH, Choi SU, Lee K, Ha JD, Lee CO, Ryu JW, Kim HR, Koh JS, Cho SY. Lee J, et al. Among authors: cho sy. Bioorg Med Chem Lett. 2012 Jun 15;22(12):4044-8. doi: 10.1016/j.bmcl.2012.04.083. Epub 2012 Apr 25. Bioorg Med Chem Lett. 2012. PMID: 22579487

10

Discovery of a potent small molecule SIRT1/2 inhibitor with anticancer effects.

Choi G, Lee J, Ji JY, Woo J, Kang NS, Cho SY, Kim HR, Ha JD, Han SY. Choi G, et al. Among authors: cho sy. Int J Oncol. 2013 Oct;43(4):1205-11. doi: 10.3892/ijo.2013.2035. Epub 2013 Jul 23. Int J Oncol. 2013. PMID: 23900402

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,123 results

Search Page